50mg Per Capsule Oral Administration NNMT Target Enzyme 22+ BHRC Locations Available Option An oral NNMT inhibitor designed to support cellular energy metabolism and metabolic function through targeted enzyme modulation
Abstract Treatment with a nicotinamide N-methyltransferase inhibitor (NNMTi
Importantly, there were no cardiovascular adverse events, no clinically significant changes in blood pressure or heart rate, no alterations in thyroid function, no immunogenicity with no anti-AOD-9604 antibodies detected, and no signs of tolerance or receptor desensitization
It also helps regulate homocysteine levels, promoting cardiovascular health
This is a valid option, especially for microdosing protocols where you need very precise measurements of small doses
Missing the "before alcohol" window does not eliminate protective effects